BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxorubicin
,
rs3825942
,
PRKCA
,
Angiogenesis
,
Inflammatory disorder
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PIMs
Summary
General Info
Curated Studies
Most Correlated Studies
Cord blood mononuclear cells depleted of PIM kinases under Th1 or Th2 polarizing conditions
Hepatocellular carcinoma MHCC-97L xenografts from BALB/c nude mice treated with PIM447
Cardiac interstitial cells from heart failure patients with PIM1 overexpression
Multiple myeloma MM.1S and U266 cells treated with PIM2 kinase inhibitor JP11646
Intrinsic glioma subtypes expression analysis
Explore Curated Studies Results
Literature
Most Relevant Literature
PIM Kinases as Potential Biomarkers and Therapeutic Targets in Inflammatory Arthritides.
Pim Kinases: Important Regulators of Cardiovascular Disease.
Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinas…
Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis.
Targeting PIM kinases in cancer therapy: An update on pharmacological small-molecule inhibitors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSP…
PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics
Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab
PIM 2.0: Patient Aligned Care Team (PACT) Intensive Management (PIM) Project
Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ